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INT ROD UCT ION
Cytomegaloviruses (CMVs) are species-specific herpesviruses 
causing severe disease in immunocompromised and immuno-
logically immature hosts. Mouse CMV (MCMV) is biologi-
cally similar to human CMV (HCMV), and therefore serves as 
a widely used model for studying CMV pathogenesis (Redde-
hase, 2002). Cells of the innate immune system play a crucial 
role in cytomegaloviral control before the initiation of specific 
immunity (Vidal et al., 2013). NK cells represent an essential 
component of innate immunity as a result of their ability to 
identify infected cells via a set of signals provided by activating 
and inhibitory receptors (Shifrin et al., 2014). The mononu-
clear phagocyte system is composed of monocytes, macro-
phages, and DCs. Monocytes are highly adaptable cells that can 
differentiate into monocyte-derived macrophages and mono-
cyte-derived DCs (Chow et al., 2011). Macrophages are pro-
fessional phagocytic cells whose main function is to inactivate 
and destroy invading pathogens (Martinez and Gordon, 2014). 
A direct macrophage infection in lymph node results in limit-
ing CMV spread (Farrell et al., 2015). Following their genetic 
programs, instructed in part by their tissue microenvironment 
and by the signals gathered through their receptors, mono-
nuclear phagocytes can adopt a variety of specific functional 
programs, encompassing, but not limited to, the well-known 
M1 versus M2 phenotypes (Italiani and Boraschi, 2014; Mur-
ray et al., 2014). The M1, with its proinflammatory features, is 
protective against viruses and other intracellular parasites. This 
phenotype is associated with the production of proinflamma-
tory cytokines such as IFN-γ or IL-12 and activation of induc-
ible nitric oxide synthase (iNOS)–NO pathway. Alternatively, 
mononuclear phagocytes can polarize to M2 cells associated 
with IL-4 and arginase production. Although the polarization 
of mononuclear phagocytes may be essential for ultimate virus 
control, the mechanisms used by various viruses to regulate 
this cellular programming are still insufficiently characterized.
The poliovirus receptor (PVR) is a ubiquitously expressed glycoprotein involved in cellular adhesion and immune response. It 
engages the activating receptor DNAX accessory molecule (DNAM)-1, the inhibitory receptor TIG IT, and the CD96 receptor 
with both activating and inhibitory functions. Human cytomegalovirus (HCMV) down-regulates PVR expression, but the sig-
nificance of this viral function in vivo remains unknown. Here, we demonstrate that mouse CMV (MCMV) also down-regulates 
the surface PVR. The m20.1 protein of MCMV retains PVR in the endoplasmic reticulum and promotes its degradation. A 
MCMV mutant lacking the PVR inhibitor was attenuated in normal mice but not in mice lacking DNAM-1. This attenuation 
was partially reversed by NK cell depletion, whereas the simultaneous depletion of mononuclear phagocytes abolished the virus 
control. This effect was associated with the increased expression of DNAM-1, whereas TIG IT and CD96 were absent on these 
cells. An increased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 and an in-
creased production of iNOS by inflammatory monocytes was observed. Blocking of CCL2 or the inhibition of iNOS significantly 
increased titer of the virus lacking m20.1. In this study, we have demonstrated that inflammatory monocytes, together with 
NK cells, are essential in the early control of CMV through the DNAM-1–PVR pathway.
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The poliovirus receptor (PVR or CD155), a member of 
the nectin protein family, serves as a ligand for the adhesion mol-
ecule DNAX accessory molecule 1 (DNAM-1; CD226; Shibuya 
et al., 1996; Bottino et al., 2003). DNAM-1 is an activating re-
ceptor expressed on the majority of immune cells, including 
monocytes, T cells, NK cells, and as a subset of B cells (Shibuya 
et al., 1996; Bottino et al., 2003; Chan et al., 2014; de Andrade et 
al., 2014; Vo et al., 2016). Upon recognition of its ligands, CD155 
(PVR) and CD112 (Nectin-2), DNAM-1 promotes NK cell 
activation and elimination of infected cells (de Andrade et al., 
2014). Recent data revealed that DNAM-1 expression marks 
an alternative maturation program of NK cells (Martinet et al., 
2015) and plays a role in the generation of memory NK cells 
(Nabekura et al., 2014). However, the role of DNAM-1 in virus 
control by various subsets of mononuclear phagocytes has not 
been so far established. PVR is also a high affinity ligand for TIG 
IT, a receptor that inhibits NK and T cell cytotoxicity (Stani-
etsky et al., 2009, 2013; Yu et al., 2009; Joller et al., 2011; Levin et 
al., 2011). Moreover, PVR binds to the CD96 (Tactile) receptor 
with both activating and inhibitory functions on NK cells (Fuchs 
et al., 2004; Chan et al., 2014). The functional outcome of a si-
multaneous PVR ligation of activating and inhibitory receptors 
on immune cells and virus control is therefore hard to predict. 
This becomes even more evident if we consider that PVR is 
expressed on the majority of somatic cells under physiological 
conditions and that its expression is induced as a consequence of 
viral infections and tumorigenesis (Chadéneau et al., 1994; Gro-
meier et al., 2000; Masson et al., 2001; Hirota et al., 2005; Toma-
sec et al., 2005; Magri et al., 2011; Vassena et al., 2013; Nabekura 
et al., 2014). Cells up-regulate PVR expression in response to 
Ras activation and DNA damage response pathway, as well as 
Toll-like receptor activation (Hirota et al., 2005; Soriani et al., 
2009; Kamran et al., 2013; Vassena et al., 2013).
HCMV encodes a protein that reduces PVR surface ex-
pression on infected cells (Tomasec et al., 2005), but the impact 
of this viral function on virus control in vivo could not be ad-
dressed due to the strict species specificity of HCMV. To over-
come this limitation and assess the relevance of viral regulation of 
PVR for virus control, we have used the infection of mice with 
MCMV. We have observed that, similar to HCMV, MCMV also 
retains PVR inside of infected cells, and we have characterized 
the viral gene involved. The deletion of the MCMV inhibitor 
of PVR dramatically enhances the virus susceptibility to innate 
immune control in DNAM-1–dependent manner. This function 
is partially dependent on NK cells that express both inhibitory 
and activating PVR receptors, but the virus control also strongly 
depends on mononuclear phagocytes that display a dramatic in-
crease of DNAM-1 expression upon infection and, at the same 
time, fail to express inhibitory PVR receptors.
RES ULTS
MCMV retains PVR in infected cells and 
prevents its surface expression
Our first goal was to assess whether MCMV, like HCMV, 
interferes with the PVR expression. Although the transcrip-
tion of PVR during MCMV infection was increased (Fig. 1, 
A and B, left; Juranic Lisnic et al., 2013), and WT MCMV 
infection resulted in up-regulation of PVR transcript com-
pared with mock-infected control, we found the surface level 
of PVR to be reduced upon MCMV infection of primary 
MEF (Fig. 1, B [right] and C). Similar down-regulation of 
surface PVR was confirmed on several cell lines infected with 
MCMV (Fig. 1 D). In contrast, UV inactivated virus did not 
down-regulate PVR, and the kinetics of PVR reduction sug-
gested that a viral gene product expressed early after infection 
is responsible for PVR down-regulation (unpublished data).
Next, we analyzed the molecular mechanism involved in 
viral PVR down-regulation. The molecular mass of the ma-
ture PVR protein in uninfected cells is between 80 and 90 kD 
(Fig. 2 A). However, the infection with MCMV resulted in the 
accumulation of a lower molecular form of PVR of ∼70 kD 
(Fig. 2 A). The treatment of lysates of MCMV-infected cells with 
EndoH revealed that the 70-kD protein form is EndoH sensitive, 
implying that MCMV retains PVR inside the cell (Fig. 2 B). 
Inhibitors of cellular degradation pathways were tested, and in-
creased PVR amounts were seen in infected cells treated with 
lactacystin, an inhibitor of proteosomal degradation, whereas the 
lysosomal inhibitor leupeptin had minimal or no effect (Fig. 2 C). 
The dominance of the proteasomal degradation was further 
confirmed by confocal microscopy (Fig. 2 D). These data show 
that, similar to HCMV, MCMV retains PVR in the ER, prevents 
its maturation, and initiates its degradation in the proteasome.
Recently, it has been shown that DCs and macrophages 
up-regulate PVR expression upon MCMV infection (Nabekura 
et al., 2014). To check whether MCMV also retains the PVR in 
cells other than primary fibroblasts, different cell lines were in-
fected with WT MCMV, and their lysates were analyzed for PVR 
retention. As shown in Fig. 2 E, the PVR retention was evident 
in all cell lines tested, including BM-derived DCs (BMDCs), the 
DC cell line DC2.4, and macrophage cell line J774. Testing the 
PVR retention in cells infected with field isolates of MCMV 
(Smith et al., 2008) showed the same PVR retention phenome-
non (Fig. 2 F). Thus, PVR retention is conserved between vari-
ous MCMV strains and functional in different cell types.
Characterization of the MCMV protein 
involved in PVR regulation
The next goal was to identify and characterize MCMV genes 
involved in PVR retention. Using a library of MCMV mutants 
with genomic deletions, we could show that the gene respon-
sible for the PVR retention is located in the m01-m22 gene 
region (Δ8 virus, Fig. 3 A). Because PVR maturation in cells 
infected with an MCMV mutant lacking the segment of first 17 
genes (Δ1 virus) was comparable with the WT MCMV, we con-
cluded that the PVR regulator must lie in the m18-m22 gene 
region (Fig. 3 A). To determine the role of individual genes in 
this region, according to previously annotated ORFs (Rawlin-
son et al., 1996), we constructed MCMV mutants with deletions 
in the genes m18, m19, m21, or m22 (Fig. 3 B, top). Because 
ORF m20 significantly overlaps with ORFs m19 and m21, it 
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was not feasible to construct individual deletion mutants for m19 
and m21 ORFs. MEF was infected with indicated mutants and 
analyzed for PVR retention. Only the MCMV mutants lacking 
ORFs m19 and m20 (Δm19/m20) and ORFs m20 and m21 
(Δm20/m21) were unable to retain PVR (Fig. 3 C). This result 
strongly suggested a role of m20 in PVR regulation.
Our previous analysis of the transcriptional profile of the 
m20 region (Juranic Lisnic et al., 2013) detected several over-
lapping transcripts. Consistent with these data, a RNA probe 
detected three dominant transcripts for the WT virus: transcripts 
of ∼3, 2, and 1 kb (Fig. 3 D, left). Because in the available viral 
mutants, either all or none of those transcripts were missing (not 
depicted), three additional viral mutants were generated to iden-
tify the transcript involved in PVR regulation (Fig. 3 B, bot-
tom). The transcriptional profile of the deletion mutant Δm19.1 
and of WT MCMV was identical, whereas the Δm20.0 mutant 
gave no detectable transcripts (Fig. 3 D, right). The transcrip-
tional profile of Δm20.1 virus showed a loss of the 2- and 3-kb 
transcripts, whereas the 1-kb transcript was preserved (Fig. 3 D). 
As can be seen from the Western blot analysis in Fig. 3 E, this 
Δm20.1 mutant was no longer able to retain the PVR.
To investigate whether the m20 region corresponding 
to the 2- and 3-kb transcripts encodes the protein that regu-
lates PVR, we expressed fragments of the predicted m20 pro-
tein as His-tagged proteins in Escherichia coli and used them 
as antigens to immunize mice. The newly generated mAb de-
tected an MCMV protein in lysates of WT MCMV-infected 
cells but not in lysates derived from cells infected with the 
Δm20.1 mutant (Fig. 4 A). A dominant signal for an ∼70-kD 
protein and a weak signal for a 55-kD form were observed. 
Endo H treatment of the 70 kD protein, named m20.1, in-
creased the amount of its deglycosylated form of ∼55 kD 
(Fig. 4 B). By immunoblotting PVR and m20.1 in the lysates 
of MEF cells infected with WT MCMV or Δm20.1 mu-
tant, we demonstrated that the retained PVR form is present 
only in cells infected with virus possessing an intact m20.1 
(Fig. 4 C). In parallel, we tested the expression of PVR on the 
surface of infected MEF cells by flow cytometry and showed 
that the virus lacking m20.1 cannot down-regulate PVR 
(Fig. 4 D). In agreement with published work (Nabekura et 
al., 2014), the infection of primary DCs with WT MCMV 
resulted in the up-regulation of PVR expression. However, 
the PVR expression was still much lower than expression on 
the surface of cells infected with the virus lacking PVR in-
hibitor (Fig. 4 D). Finally, we confirmed that m20.1 protein is 
required for PVR retention showing the protein–protein in-
Figure 1. MCMV up-regulates PVR transcription but 
down-regulates its surface expression. (A) PVR locus 
with aligned reads from RNASeq analysis of infected and 
mock-infected MEF (Juranic Lisnic et al., 2013; left). Es-
timation of PVR gene expression by RPKM (reads per ki-
lobase of exon model per million mapped reads; right). (B) 
Level of PVR transcript was measured in mock-infected 
BALB/c MEF and in WT MCMV-infected cells (left) that 
down-regulated PVR after 18  h p.i. (right) by quantita-
tive RT-PCR. Data are representative from two indepen-
dent experiments. ***, P < 0.001. (C) WT MCMV (1 PFU/
cell, 16 h) or mock-infected MEFs were analyzed for the 
surface PVR by anti-PVR mAb or the isotype control. (D) 
Indicated cell lines, WT MCMV (3 PFU/cell, 16 h) or mock 
infected, were analyzed for the surface PVR expression. 
The analysis of surface PVR expression (C and D) was in-
dependently replicated six times.
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teraction between the m20.1 and the ER retained PVR form 
of ∼70 kD by coimmunoprecipitation (Fig. 4 E). Altogether, 
we have characterized the viral protein encoded in the m20 
gene region and proved that the ER-resident glycoprotein 
m20.1 is responsible for PVR retention.
In vivo attenuation of the MCMV mutant lacking the PVR 
inhibitor is partially mediated by NK cells
The next aim was to assess whether CMV regulation of 
PVR has functional relevance in vivo. BALB/c mice were 
i.v. injected with Δm20.1 mutant or the respective con-
trol virus and viral titers in organs were determined 4 d 
p.i. (Fig.  5  A). The virus lacking the PVR inhibitor was 
strongly attenuated in vivo. Attenuation levels were simi-
lar in immunocompetent animals, as well as in SCID mice, 
suggesting a crucial role of innate immune cells in the con-
trol of the Δm20.1 virus (Fig.  5 B). These results indicate 
that viral regulation of PVR inhibits the early virus control 
in vivo. The infection of newborn mice, which are still im-
munologically immature and very sensitive to MCMV in-
Figure 2. MCMV blocks PVR maturation in the ER and promotes its proteasomal degradation. (A) PVR was immunoblotted from WT MCMV (1 PFU/
cell, 20 h) or mock infected MEF lysates with anti-PVR mAb; actin is shown as a loading control and MCMV m04 protein as a control of infection. Immuno-
blotting was independently replicated six times. (B) B12 cells were infected with WT MCMV (3 PFU/cell, 16 h) or mock infected. PVR was immunoblotted from 
EndoH-treated or untreated lysates (top); actin is shown as a loading control and MCMV M57 protein as a control of infection (bottom). (C) B12 cells were 
infected with WT MCMV (3 PFU/cell) and at 4 h p.i. treated with lactacystin (10 µM), leupeptin (75 µg/µl) or left untreated. 16 h p.i. lysates were analyzed 
with anti-PVR mAbs; actin is shown as a loading control. (D) B12 cells were infected with the virus lacking viral Fc receptor m138, treated as indicated for 
C and analyzed with anti-PVR mAbs, followed by FITC-labeled secondary Abs by IF. All images were equally adjusted using FluoView software; γ adjustment, 
1.8; bar, 10 µm. Experiments with lactacystin and leupeptin were independently replicated two times. (E) PVR was immunoblotted from mock or WT MCMV 
(3 PFU/cell, 20 h) infected lysates of indicated cells; actin is shown as a loading control. (F) PVR was immunoblotted from lysates of B12 cells infected with 
WT MCMV or three field isolates (2.5 PFU/cell, 16 h); actin is shown as a loading control. PVR immunoblotting (E and F) was repeated independently on each 
cell line at least two times.
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fection, also results in attenuation of mutant virus in several 
tested organs (Fig. 5 C).
To assess whether the attenuated phenotype of the 
Δm20.1 mutant is the result of an enhanced sensitivity to NK 
cells, BALB/c and C57BL/6 mice were infected with either 
Δm20.1 or control virus. Several mice in each group were 
depleted of NK cells, and virus titers were determined on day 
4 p.i. (Fig. 5 E). The results clearly demonstrated that NK cells 
contribute to efficient control of a virus lacking the PVR in-
hibitor, to varying extents depending on the tissue examined. 
These in vivo findings are in accordance with enhanced pro-
duction of IFN-γ by NK cells derived from Δm20.1-infected 
mice compared with cells derived from mice infected with the 
control virus (Fig. 5 D). However, there were still significant 
differences between the titer of control virus and the Δm20.1 
mutant after NK cell depletion, indicating that additional in-
nate immune control mechanisms are involved (Fig. 5 E).
Dominant expression of DNAM-1 on inflammatory 
monocytes and macrophages after MCMV infection
The enhanced susceptibility of MCMV lacking the PVR in-
hibitor to immune control indicates a role of the DNAM-1–
Figure 3. PVR is regulated by a gene located in the m20 gene region. (A) B12 cells were infected with WT, Δ8 (Δm01-m22) or Δ1 (Δm01-m17) MCMV 
(3 PFU/cell) and immunoblotted with anti-PVR mAbs; actin is shown as a loading control. (A and B) White boxes represent deleted gene regions in recom-
binant viruses. (B) Previously annotated ORFs are shown as white arrows. The black arrow represents the RNA probe used for the Northern blot analysis 
in D. (C) PVR was immunoblotted from lysates of B12 cells infected with indicated mutants (3 PFU/cell, 16 h); actin is shown as a loading control. (D) MEF 
was infected with indicated viruses (0.3 PFU/cell, 48 h) or left uninfected. Transcripts were identified using the RNA probe (B). WT MCMV lane is from dif-
ferent gel, whereas Δm19.1, Δm20.0 and Δm20.1 are parts of the same gel analyzed with the same exposure. (E) MEF was infected with indicated viruses 
(1 PFU/cell, 20 h). PVR was immunoblotted from cell lysates. All experiments (A–E) were independently replicated at least two times.
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PVR pathway. Thus, we analyzed the expression of PVR 
receptors on NK cells and mononuclear phagocytes (Fig. 6, 
A–C). We found that the frequency of NK cells expressing 
DNAM-1 is higher in mice infected with MCMV, irrespec-
tive of the virus used. Yet the frequency of NK cells expressing 
TIG IT was also significantly higher in infected mice, whereas 
the frequency of CD96+ NK cells was significantly lower 
(Fig. 6 A). This fact might explain why NK cells fail to control 
Δm20.1 more efficiently. In contrast to NK cells, mononuclear 
phagocytes express almost no other PVR receptors except 
DNAM-1 (Fig. 6 B and not depicted). Moreover, we found 
that upon infection, the frequency of DNAM-1–expressing 
inflammatory monocytes (Fig. 6 B) and splenic macrophages 
(Fig. 6 C) was dramatically increased. The surface density of 
DNAM-1 on all splenic macrophage subsets (including red 
pulp, marginal metallophilic, and marginal zone macrophages) 
was up-regulated upon infection (Fig. 6 C, bottom). Based on 
the pattern of expression of DNAM-1, TIG IT, and CD96 on 
mononuclear phagocytes, it appears to assume dominance of 
DNAM-1 in virus control.
Mice infected with Δm20.1 have higher level of 
proinflammatory cytokines in sera, as well as increased 
production of nitric oxide by inflammatory monocytes
Cytokine profiles in the sera of Δm20.1-infected mice were 
in line with a more efficient antiviral activity (Fig. 6 D). Al-
Figure 4. Characterization of the viral 
protein m20.1 that retains PVR. (A) m20.1 
was immunoblotted from MCMV (indicated vi-
ruses, 1 PFU/cell, 20 h) or mock infected MEF 
lysates with anti-m20.1 mAb; actin is shown 
as a loading control and MCMV m04 protein 
as a control of infection. (B) MEF was infected 
with indicated viruses (0.8 PFU/cell; 20  h). 
MCMV m20.1 and m04 proteins were immu-
noblotted from EndoH-treated or untreated 
lysates with corresponding Abs; m04 is shown 
as a control of infection and EndoH treatment. 
(C) B12 cells were infected with indicated vi-
ruses (3 PFU/cell, 20 h) or mock infected. PVR 
and m20.1 proteins were immunoblotted from 
lysates with rat anti–mouse PVR mAb and 
anti-MCMV m20.1 mAb, respectively. Actin 
is shown as a loading control and m04 as a 
control of viral infection. Different parts of 
the same gel analyzed by same exposure are 
shown. (D) BMDCs or MEF cells were infected 
with either WT MCMV or Δm20.1 virus (3 or 
1 PFU/cell, respectively). Infected and mock 
infected cells were analyzed for the surface 
PVR by anti-PVR mAb, or the isotype control, 
followed by anti–rat PE. (E) PVR was immu-
noblotted from MCMV-infected MEF lysates 
with anti-PVR mAb (left). The m20.1 was im-
munoprecipitated from the same lysates with 
the anti-m20.1 mAb or the control mAb, and 
PVR was subsequently immunoblotted from 
precipitates with anti-PVR mAb (right). All 
experiments (A–E) were independently repli-
cated at least two times.
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though we were unable to define which subpopulations of 
mononuclear phagocytes are responsible for differences in 
cytokine production between WT- and Δm20.1-infected 
mice, the sera of Δm20.1-infected mice 1.5 d p.i. showed 
increased level of IL-12p70, G-CSF, and IL-6, cytokines char-
acteristic for the proinflammatory response of M1 mononu-
clear phagocytes (Martinez and Gordon, 2014). The level of 
IFN-γ, a major NK cell cytokine and an important activator 
Figure 5. Heavy attenuation of MCMV lacking PVR inhibitor is caused in part by NK cells. BALB/c mice (A) or C57BL/6 SCID mice (B) were i.v. injected 
with 2 × 105 PFU/mouse (A) or 5 × 105 PFU/mouse (B) of Δm20.1 MCMV mutant generated on Δm157 background and Δm157 MCMV as a control virus. 
Titers in organs of individual mice 4 d p.i. are shown (circles); horizontal bars indicate the median values. (C) Newborn BALB/c mice were i.p. injected with 
400 PFU/mouse of Δm20.1 MCMV mutant generated on Δm157 background or Δm157 MCMV. Titers in organs of individual mice 11 d p.i. are shown (cir-
cles); horizontal bars indicate the median values. Results from one of the three independent experiments (A) and one of the two independent experiments 
(B and C) are shown, with minimum four animals per group. DL, detection limit. *, P < 0.05; **, P < 0.01. (D) BALB/c mice were i.v. injected with 2 × 105 PFU 
of WT MCMV, Δm20.1 MCMV, or left uninfected. IFN-γ expression by splenic NK cells was determined by intracellular FACS analysis 1.5 d p.i. n = 5 animals; 
mean + SD; *, P < 0.05. Data are representative from three independent experiments. (E) C57BL/6 or BALB/c mice depleted for NK cells or undepleted were 
i.v. injected with 5 × 105 PFU/mouse or 2 × 105 PFU/mouse of Δm157 MCMV (control virus) or Δm20.1 mutant generated on Δm157 background. Titers in 
organs of individual mice 4 d p.i. are shown (circles); horizontal bars indicate the median values. Results from one of the two independent experiments with 
minimum three animals per group are shown. *, P < 0.05; **, P < 0.01.
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of mononuclear phagocytes that is induced upon DNAM-1 
signaling (de Andrade et al., 2014), was also elevated in the 
sera of mice infected with Δm20.1 (Fig. 6 D). Accordingly, 
the levels of IL-10, a hallmark of antiinflammatory response 
and inhibition of proinflammatory cytokine expression in 
macrophages (Martinez and Gordon, 2014), were reduced in 
the sera of mice infected with Δm20.1 virus. The decrease 
was also observed for the CXCL13, IL-10–induced chemo-
attractant, and the antiinflammatory cytokine tissue inhibitor 
of metalloproteinases (TIMP-1). The level of another proin-
Figure 6. Macrophages and inflammatory 
monocytes in spleen selectively up-regulate 
PVR receptor DNAM-1 upon CMV infection. 
(A) BALB/c mice were i.v. injected with 2 × 105 PFU 
of WT MCMV, Δm20.1 MCMV, or left uninfected. 
1.5 d p.i. percentages of DNAM-1+, CD96+, or 
TIG IT+ NK cells were determined from spleen by 
surface FACS analysis. (B) Mice were i.p. injected 
with 2 × 105 PFU of WT MCMV, Δm20.1 MCMV, 
or left uninfected and the expression of DNAM-
1, CD96, and TIG IT determined on inflammatory 
monocytes by FACS analyses. (C) BALB/c mice were 
treated as described in B, and the expression of 
DNAM-1 on splenic macrophages determined by 
FACS analyses (RP, red pulp; MM, marginal metal-
lophilic; MZ, marginal zone macrophages). (D) Dot 
blot analysis of cytokines, with capture antibod-
ies spotted onto a membrane, in the sera of mice 
infected with WT MCMV or Δm20.1 MCMV. Two 
membranes with 40 different antibodies captured 
(in duplicate) were tested in each experiment with 
the sera of either WT MCMV or Δm20.1 MCMV in-
fected mice. Experiment was repeated twice with 
different sera. Data selected for cytokines that 
were consistently up-regulated or down-regulated 
in both experiments and whose fold change was 
≥2 in at least one of the experiments (*). Shown 
are mean values plus range. (E) BALB/c mice were 
treated as described in B. 1.5 d p.i. iNOS expression 
by inflammatory monocytes was determined by 
intracellular FACS analysis. (A and B [top] and C 
and E) n = 5 animals per group; mean + SD. *, P < 
0.05; **, P < 0.01; ***, P < 0.001.
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flammatory cytokine secreted by macrophages, IL-1, was not 
evidently different; however, Δm20.1-infected mice had a 
lower amount of the IL-1 receptor antagonist (IL-1ra). Thus, 
the data indicate that m20.1 down-regulates the proinflam-
matory cytokine response via the PVR–DNAM-1 pathway.
Because cytokines induce iNOS to produce NO as an 
important effector mechanism of mononuclear phagocytes, 
we compared the production of iNOS by all major subsets 
of splenic mononuclear phagocytes, including red pulp mac-
rophages, marginal metallophilic macrophages, and marginal 
zone macrophages, conventional DCs, plasmacytoid DCs, and 
inflammatory monocytes derived from mice infected with 
Δm20.1 or control MCMV (Fig. 6 E and not depicted). In-
flammatory monocytes produced more iNOS after infection 
with Δm20.1 virus compared with WT MCMV (Fig. 6 E), 
suggesting their dominant role in observed phenotype in vivo.
DNAM-1– and iNOS-dependent attenuation of Δm20.1 
by inflammatory monocytes
To assess the role of DNAM-1 in the early attenuation of 
Δm20.1, we used DNAM-1−/− mice (Gilfillan et al., 2008). 
In mice lacking DNAM-1, the differences in virus titers 
between WT and Δm20.1 virus were reduced or abolished 
(Fig. 7 A). These findings are in accordance with the data ob-
tained on iNOS production in DNAM-1−/− mice (Fig. 7 B). 
Whereas in C57BL/6 mice the frequency of iNOS+ inflam-
matory monocytes was higher upon Δm20.1 infection com-
pared with the WT MCMV infection, this difference was 
abolished in DNAM-1−/− mice.
To further confirm the contribution of mononuclear 
phagocytes in the control of virus lacking PVR inhibitor, we 
treated infected mice with clodronate liposomes (Fig. 7 C). 
The treatment resulted in an increase of the WT virus titer, 
yet the increase of Δm20.1 virus titer was much more dra-
matic. Moreover, the treatment resulted in abolishment of 
the difference in titers between Δm20.1 and WT MCMV 
virus (Fig.  7  C). In agreement with the results shown in 
Fig.  5  E, the depletion of NK cells significantly affected 
the virus control, but the differences in virus titers between 
WT- and Δm20.1 MCMV-infected mice depleted of NK 
cells were still statistically significant. The simultaneous de-
pletion of NK cells and mononuclear phagocytes by clod-
ronate liposomes was necessary to abolish virus control in 
the spleen. These results indicate that, in addition to NK 
cells, mononuclear phagocytes play a role in attenuation of 
virus lacking PVR inhibitor.
To evaluate the impact of inflammatory monocytes that 
show higher level of iNOS expression in mice infected with 
Δm20.1 MCMV (Figs. 6 E and 7 B), we blocked CCL2, a 
chemokine required for exit of these cells from the BM and 
their recruitment to the inflamed tissue. Mice were treated 
with blocking anti-CCL2 antibodies, and virus titers were 
determined 4 d p.i. (Fig.  7 D). The blocking of CCL2 in-
creased the titer of Δm20.1 and abolished the differences be-
tween viruses in spleen, whereas in liver the blocking effect 
was partial. To further confirm that the differential levels of 
iNOS can explain the attenuation of Δm20.1 virus, we per-
formed blocking of the iNOS–NO pathway by treating the 
mice with the inhibitor N(G)-nitro-l-arginine methyl ester 
(l-NAME; Fig. 7 E). Our results demonstrate that blocking 
of iNOS production in vivo significantly increased the titer of 
the virus lacking PVR inhibitor but had no significant effect 
on the titer of WT MCMV virus.
DIS CUS SION
While the outcome of viral down-regulation of cellular ligands 
for the activating receptors can be predicted, the situation is 
more complex for ligands such as PVR, which are recognized 
by both activating and inhibitory receptors (Martinet and 
Smyth, 2015). The outcome depends not only on the level of 
ligand down-regulation but also on the expression level and the 
affinity of its respective receptors. In this study, we have shown 
that the surface level of PVR is down-regulated by the MCMV 
protein m20.1, which affects the maturation of PVR in the 
ER, leading to its proteasomal degradation. The virus mutants 
lacking a PVR inhibitor are severely attenuated in vivo, indi-
cating the dominance of the activating receptor DNAM-1 in 
deciding the outcome of the modulation of PVR levels. The 
early attenuation of mutant viruses lacking the PVR inhibitor 
was only partially dependent on NK cells, which can be ex-
plained by the fact that these cells induce both activating and 
inhibitory PVR receptors upon infection. However, the deple-
tion of mononuclear phagocytes abolished the virus control, 
which correlates with dramatic up-regulation of DNAM-1 
and absence of inhibitory PVR receptors on these cells even 
upon infection. In particular, we identified CCL2-dependent 
inflammatory monocytes as a major subpopulation controlling 
the virus lacking the PVR inhibitor via induction of iNOS.
Given that HCMV also retains PVR (Tomasec et al., 
2005), one can assume that PVR regulation by this virus has 
a similar impact on the virus control as the one shown for 
the MCMV. Interestingly, in HCMV, the gene that regulates 
PVR, UL141, also inhibits the expression of another ligand 
of DNAM-1, nectin-2 (CD112; Prod’homme et al., 2010). 
In contrast, MCMV m20.1 solely regulates PVR, whereas 
another, thus far unidentified gene, is involved in the regu-
lation of nectin-2 (unpublished data). Although HCMV and 
MCMV use different genes for regulation of PVR, the same 
functional outcome indicates the importance of DNAM-1 in 
virus control. It has been shown that inhibitory receptor TIG 
IT has a much stronger affinity for PVR than activating recep-
tor DNAM-1 (Yu et al., 2009), and this might have functional 
consequences during CMV infection. Here, we demonstrated 
that MCMV infection partially reduces the PVR expression 
instead of its complete abolishment from the cell surface. This 
pattern is preserved even in cells that up-regulate PVR surface 
levels upon MCMV infection, such as DCs (this study and 
Nabekura et al., 2014). Thus, in all infected cells, the PVR ex-
pression after Δm20.1 MCMV infection exceeded the levels 
that were observed after WT MCMV infection. We hypoth-
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Figure 7. DNAM-1– and iNOS-dependent control of Δm20.1 MCMV by inflammatory monocytes. (A) C57BL/6 or DNAM−/− mice were i.v. injected 
with 5 × 105 PFU of Δm157 MCMV (control virus) or Δm20.1 mutant generated on Δm157 background. Titers in organ of individual mice 4 d p.i. are 
shown (circles); horizontal bars indicate the median values; Results from one of the two independent experiments with minimum four animals per group 
are shown. *, P < 0.05. (B) C57BL/6 or DNAM−/− mice were i.p. injected with 5 × 105 PFU of Δm157 MCMV (control virus), Δm20.1 mutant generated on 
Δm157 background, or left uninfected. 1.5 d p.i. iNOS expression by inflammatory monocytes was determined by intracellular FACS analysis. n = 5 animals; 
mean + SD; *, P < 0.05. (C) BALB/c mice were injected i.v. with 2 × 105 PFU of indicated viruses. For depletion of NK cells, mononuclear phagocytes or both 
subsets, groups of mice were treated with anti-AGM1, clodronate liposomes, or both, and virus titers were determined 4 d p.i. Group of mice injected with 
PBS was used as control. Results from one of the three independent experiments with minimum four animals per group are shown. Shown are mean values 
plus SEM. *, P < 0.05; **, P < 0.01. (D) BALB/c mice were injected i.p. with 2 × 105 PFU of indicated viruses. 1 d before infection and on the day of infection, 
in vivo blocking of CCL2 was performed by i.p. injection of the mAbs to CCL2. Titers in organs of individual mice 4 d p.i. are shown (circles). Results from 
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esize that MCMV might fine-tune the expression of PVR, 
to avoid recognition by the activating receptor while, at the 
same time, preserving ligation of the inhibitory receptor. In 
any case, this strategy could not protect the virus from control 
by mononuclear phagocytes, as we have shown that these cells 
express almost no inhibitory PVR-ligating receptors.
Previous studies have shown that inflammatory mono-
cytes may play a dual role in antiviral responses because their 
functions can be beneficial or harmful, depending on the 
model and context of infection (Iijima et al., 2011; Lim et 
al., 2011; Daley-Bauer et al., 2012). In the context of CMV 
infection, monocytes have mainly been identified as cellu-
lar targets for viral dissemination and latency (Mitchell et 
al., 1996; Smith et al., 2004; Hargett and Shenk, 2010) or 
as modulators of antiviral immune response mediated by 
other immune cells (Hokeness et al., 2005; Daley-Bauer 
et al., 2012). Recently, it has been shown that patrolling, 
but not inflammatory, monocytes are involved in MCMV 
dissemination (Daley-Bauer et al., 2014), whereas inflam-
matory monocytes modulate adaptive immunity to MCMV 
(Daley-Bauer et al., 2012). However, less is known about 
possible direct antiviral effects of inflammatory monocytes 
in MCMV infection. Inflammatory monocytes use the same 
mechanisms as macrophages to control viruses, such as pro-
duction of inflammatory cytokines or NO (Serbina et al., 
2008), Indeed, NOS-deficient mice are more susceptible 
to MCMV infection (Noda et al., 2001). In line with this, 
our results show an increased iNOS production by inflam-
matory monocytes in mice infected with virus lacking the 
PVR inhibitor, which might explain more efficient con-
trol of this viral mutant. The role of inflammatory mono-
cyte in iNOS-dependent control of MCMV was further 
confirmed by treatment of mice with the iNOS inhibitor 
l-NAME and by blocking of CCL2 chemokine. It is well 
established that inflammatory monocytes can give rise to 
tissue macrophages and DCs (Guilliams et al., 2014; Italiani 
and Boraschi, 2014). Both subsets have been shown to play 
a role in virus control and immunoregulation (Farrell et al., 
2015; Gaya et al., 2015; Holzki et al., 2015). Thus, it is pos-
sible that these cells also contribute to enhanced control of 
the Δm20.1 virus. This particularly refers to macrophages, 
as our data show that all three splenic macrophage subsets 
selectively up-regulate DNAM-1 upon MCMV infection, 
whereas no such up-regulation was observed on DCs (un-
published data). Indeed, the results obtained after clodronate 
treatment support the role of other phagocytes.
Inflammatory cytokines promote the production of 
CCR2-binding chemokines and regulate monocyte/macro-
phage emigration from the BM, as well as their recruitment 
into the tissues in response to MCMV infection (Hokeness 
et al., 2005; Crane et al., 2009; Wikstrom et al., 2014). In the 
sera of mice infected with the mutant lacking the PVR in-
hibitor, there was a shift toward proinflammatory cytokines, 
such as IL-12, which is crucial for IFN-γ production in the 
DNAM-1–driven response of NK cells (Magri et al., 2011). 
IL-12 has been shown to have a strong stimulating effect 
specifically on DNAM-1+ NK cells (Martinet et al., 2015). 
In line with this, our data show that IFN-γ, the major NK 
cell cytokine and an activator of macrophages, which is in-
duced upon DNAM-1 signaling, was increased in the sera 
and in the splenic NK cells of mice infected with Δm20.1. 
Although it has been shown that pDCs are the main pro-
ducers of IL-12 during early MCMV infection (Zucchini et 
al., 2008; Alexandre et al., 2014), alternative population of 
cells, such as CD11b+ DCs, can take over IL-12 production 
(Dalod et al., 2003). For example, CD14+ PBMCs are the 
main source of IL-12 during HCMV infection (Rölle et al., 
2014). Moreover, one has to take into account the plasticity 
of the mononuclear phagocytes. On one hand, tissue mac-
rophages polarize into M1, proinflammatory macrophages, 
and on the other hand, monocyte-derived macrophages 
and monocyte-derived DCs perform partially overlapping 
functions, including the secretion of proinflammatory cy-
tokines (Italiani and Boraschi, 2014). In addition, mono-
cytes can up-regulate CD11c without converting into DCs 
(Drutman et al., 2012). The discrimination of mononuclear 
phagocytes and their subpopulations is further complicated 
by the lack of selective markers (Gautier et al., 2012) and 
by the fact that MCMV infection or TLR signaling by it-
self changes the surface expression of several markers, lead-
ing frequently to their down-regulation as in the case of 
CD169, F4/80, CD11c, CD115, and others (Heise and Vir-
gin, 1995; Singh-Jasuja et al., 2013; Daley-Bauer et al., 2014; 
Farrell et al., 2015). Knowing that most chemokines and 
cytokines can be produced by several cell types (Dalod and 
Biron, 2013), and that location, timing, and overall vigor 
of the immune response during CMV infection can affect 
their production, further studies are needed to determine 
the contribution of individual subsets to systemic cytokine 
levels in MCMV-infected animals.
Proinflammatory cytokines are also involved in im-
munopathology. HCMV is the most common cause of 
intrauterine viral infections and a major viral cause of 
neurological disease in children, including disorders of 
perceptual senses, such as hearing (Britt et al., 2013). A 
model of MCMV-induced hearing loss also points to a 
role of virus-induced inflammation (Bradford et al., 2015). 
Accordingly, antiinflammatory drugs can reduce such de-
velopmental abnormalities in MCMV-infected newborn 
mice (Kosmac et al., 2013). We assume that a tight con-
one of the two independent experiments with four to five animals per group are shown. *, P < 0.05. (E) BALB/c mice were injected i.v. with 2 × 105 PFU of 
indicated viruses. For blocking of NOS, mice were given sterile drinking water with or without l-NAME 3 d before infection and throughout the course of 
infection. Results from one of the two independent experiments with five animals per group are shown. *, P < 0.05; **, P < 0.01.
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trol of activation of mononuclear phagocytes by PVR 
down-modulation might be beneficial for MCMV-in-
fected newborn mice, particularly keeping in mind that 
immune mechanisms that are supposed to contain virus 
infection (e.g., NK cells and CD8 T cells) are not fully de-
veloped at this postnatal period. Therefore, the fact that the 
virus lacking PVR inhibitor is attenuated in neonatally in-
fected mice can be a double-edged sword. Further studies 
are needed to assess the significance of viral regulation of 
PVR in reducing inflammation, histopathology, and neu-
ronal abnormalities caused by cytokines and other soluble 
factors induced by the infection.
In conclusion, our data provide the strongest evidence 
so far for CMV control by mononuclear phagocytes and NK 
cells in which the DNAM-1–PVR pathway plays an essential 
role. In addition, the results demonstrate novel mechanism of 
viral regulation of paired receptors, which also differ in affin-
ity to their common ligand. These results may be instrumen-
tal to identifying novel intervention targets and in designing 
novel vaccines and vaccine vectors. Our data also suggest that 
preservation of mononuclear phagocytes in individuals under 
immunodepletion regimens could reduce the risk of the pri-
mary viral infection and reactivation of latent viruses.
MAT ERI ALS AND MET HODS
Cells
SVEC4-10 (CRL-2181; ATCC), M2 10B4 (CRL1972; 
ATCC), J774A.1 (TIB67; ATCC), B12 (immortalized BAL-
B/c fibroblasts), and MEF (mouse embryonic fibroblasts from 
BALB/c mice) were cultivated in Dulbecco’s modified Ea-
gle’s medium supplemented with 10 or 3% fetal calf serum. 
DC2.4 cells (immortalized DCs) were cultivated in RPMI 
medium w/o mercaptoethanol. SP2/O (CRL 1581; ATCC) 
cells were cultured in supplemented or plain RPMI medium. 
To obtain BMDCs, BMDCs were cultured for 7 d in 10% 
RPMI complemented with GM-CSF.
Viruses
The bacterial artificial chromosome (BAC)–derived MCMV, 
MW97.01, has previously been shown to be biologically equiva-
lent to the MCMV Smith strain (VR-194 [reaccessioned as VR-
1399]; ATCC) and is here referred to as WT MCMV (Wagner 
et al., 1999). WT MCMV strains and various MCMV mutants 
used in these experiments were propagated on MEF, and virus 
stocks were prepared as described previously (Brune et al., 2001). 
MCMV mutants lacking different sets of genes or gene frag-
ments were generated by site-directed mutagenesis on MCMV 
BAC, as described previously for Δ8(m01-m22), Δ1(m01-m17; 
Brune et al., 2006), Δm138/fcr-1 mutant (Crnković-Mertens 
et al., 1998), and Δm157 mutant (Bubić et al., 2004). The new 
MCMV mutants in region m18-m22 were generated on WT 
MCMV BAC. To avoid interference with NK cell activation via 
Ly49H receptor, a set of mutants in this region was also generated 
on the backbone of Δm157 BAC (Bubić et al., 2004). Primers 
used for generation of MCMV mutants of the m18-m22 re-
gion on WT MCMV/C3X background are as follows: Primers 
for Δm20.1, 5′-M20_1-ACC TGG CCT ATA CTC ACG TTG 
CCG TTG TGC AGG TCC GAG AAC ATG AGG ACG ACG 
ACG ACA AGT AA, 3′-M20_1-GTA AAT GGA CGG TTA TTA 
AAA GAT GAG GTC GTG TGA CCT CTG TTA CAG GAA 
CAC TTA ACG GCT GA; primers for Δm20.0, 5′-MP ACA 
CCC ATC CCC TAC CAT TAT GTT TCC CCG GTT CAT 
CTC GAG ATC CTC AGA GTA AAC TTG GTC TGA CAG 
TTA CC and 3′-MP TGG GCC AAC GAT CTG GCC GGA 
ATG TAT CGC TGC GCC GTC TAC TTC ACC GCC GTG 
GAC TCC AAC GTC AAA GG; primers used for generation of 
MCMV mutants on Δm157 background, primers for Δm18 
virus, 5′-M18-Kan TCG TCG TTA AGT ATT TCT GCA AAG 
CAT TCG ACG TCG TAA TCG CTA ACG ACG CCA GTG 
TTA CAA CCA ATT AACC and 3′-M18-Kan GAC ACT 
GGG CAC GGT ACC CGA ACG AGA GGT TCG AGG GTC 
GTC AGA GCG CCC GAT TTA TTC AAC AAA GCC ACG; 
primers used for Δm19/m20 virus, 5′-M19-Kan ATC ATC 
GCC ACA CCC ATC CCC TAC CAT TAT GTT TCC CCG 
GTT CAT CTC GAG CCA GTG TTA CAA CCA ATT AACC 
and 3′-M19-Kan AGG CGA GTC TTC GGA GCT GTA CGC 
TAG GGC GAT CGC CAT CAC CCT CTT CAC GAT TTA 
TTC AAC AAA GCC ACG; primers used for Δm20/21 virus, 
5′-M20-Kan TGA AGA GGG TGA TGG CGA TCG CCC TAG 
CGT ACA GCT CCG AAG ACT CGC CTG CCA GTG TTA 
CAA CCA ATT AACC and 3′-M21-Kan GTC ATG TAA ATG 
GAC GGT TAT TAA AAG ATG AGG TCG TGT GAC CTC 
TGT TAC GAT TTA TTC AAC AAA GCC ACG; primers used 
for Δm22 virus, 5′-M22-Kan TAG CGC CTC GAT CGA CGA 
GCG TCG GAC AAA GAA ACC GGG AGA AGA AGG CCA 
GTG TTA CAA CCA ATT AACC and 3′-M22-Kan TGA TCG 
GAT CGG ACG GAC CGG ACG GAC CGC GAC TGC TTG 
TCG GGC GGG TGC GAT TTA TTC AAC AAA GCC ACG; 
primers used for Δm19.1(B84) virus, 5′-M19-MP-Kan AAG 
ACG CTC GTC TTA TAA CAC CGA CTG ACG TTT ACT 
CCG ACT CAG GAT GCC AGT GTT ACA ACC AAT TAA CC 
and 3′-M19-MP-Kan AAA TCA TAC CAT TCG AGT CCG 
ATG TCC GTG TCT CAC TTC TGG TTT CTT TGC GAT 
TTA TTC AAC AAA GCC ACG; primers used for Δm20.1(B85) 
virus, 5′-M20-MP-Kan ACC AAC ACC TGG CCT ATA CTC 
ACG TTG CCG TTG TGC AGG TCC GAG AAC ATG CCA 
GTG TTA CAA CCA ATT AACC and 3′-M21-Kan GTC ATG 
TAA ATG GAC GGT TAT TAA AAG ATG AGG TCG TGT GAC 
CTC TGT TAC GAT TTA TTC AAC AAA GCC ACG.
Northern blot
Northern blot analysis was performed as described previously 
(Juranic Lisnic et al., 2013). In brief, RNA was isolated using 
the TRIzol reagent from mock or MCMV-infected MEF 
(0.3 PFU/cell). 1 µg of RNA was separated, transferred to 
membrane, and cross-linked by UV irradiation. Membranes 
were incubated with DIG-labeled probes overnight at 67°C. 
Single-stranded RNA probe was generated by in vitro tran-
scription from PCR products amplified with m19–m20 
primers (Juranic Lisnic et al., 2013).
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qPCR
BALB/c MEF was infected with 1 PFU of indicated viruses. 
The cells were collected with 2 mM EDTA, washed in PBS, 
and lysed in RLT buffer (QIA GEN). RNA was isolated 
using RNEasy Plus Mini kit according to manufacturer’s 
(QIA GEN)instructions. RNA integrity was visualized on 
RNA Bleach gel (Aranda et al., 2012). RNA was treated 
with DNaseI (New England Biolabs), and then reverse tran-
scribed using Protoscript II First Strand Synthesis kit (New 
England Biolabs) with random primers mix according to 
the manufacturer’s protocol. PVR transcript was quantified 
in triplicates on Applied Biosystems’ 7500 Instrument using 
TaqMan assay (Thermo Fisher Scientific) for mouse PRV 
(Mm00493398_m1) with GAP DH as endogenous control 
(Mm99999915_g1). No amplification from either PVR or 
GAP DH probes was observed in either RT controls or NTC 
samples. Relative quantitation was calculated using ΔΔCT 
method on 7500 Software V 2.0.5.
Protein expression and purification
Immunogens were subcloned into pQE-30 vector encod-
ing N-6xHis tagged proteins, induced with 1  mM IPTG 
in BL21 DE3 cells, and purified under denaturing condi-
tions using AKTA-prime. The pellet was lysed using 6  M 
guanidine hydrochloride, 20  mM sodium phosphate, and 
500 mM sodium chloride; mixed in 1:1 ratio with the 8 M 
urea, 20 mM sodium phosphate, and 500 mM sodium chlo-
ride; and then applied to the Ni-NTA column. After elution 
(8 M urea, 20 mM sodium phosphate, and 500 mM sodium 
chloride, pH 4.0), the immunogen was diluted in 8 M urea, 
50  mM sodium phosphate, 300  mM sodium chloride, and 
10 mM imidazole (pH 7.4) and polished using Co-NTA col-
umn and the (8 M urea, 50 mM sodium phosphate, 300 mM 
sodium chloride, and 150 mM imidazole) elution conditions.
Generation of anti m20.1 mAbs
BALB/c mice were injected with 50 µg of immunogen in 
complete Freund’s adjuvant and, 2 wk later, in incomplete 
Freund’s adjuvant. After 2 wk, the sera were screened for the 
antibody titer. The best responders were boosted with the im-
munogen in PBS. 3 d later, spleen cells were collected, and 
after lysis of red blood cells, fused with SP2/0 cells. The cells 
were seeded in 20% RPMI 1640 medium containing hypox-
anthine, aminopterine, and thymidine for hybridoma selec-
tion and screened for mAbs using ELI SA.
Flow cytometry
Uninfected or cells infected with indicated MCMV strains 
were stained for the surface PVR using rat anti–mouse PVR 
clone 3F1 (Hycult Biotech), followed by goat anti–rat IgG 
F(ab′)2-PE (sc-3829) or goat anti–rat IgG, F(ab’)2-FITC (sc-
3825). Rat IgG2a isotype control (clone MEL.14) was gener-
ated and characterized in our laboratory.
Splenic leukocytes were prepared as previously de-
scribed, and Fc receptors were blocked with 2.4G2 antibody 
(Yokoyama and Kim, 2008). The following antibodies, pur-
chased from eBioscience or BD, were used: CD3ε (145-2C11), 
CD49b (DX5), NKp46 (29A1.4), TIG IT (GIGD7 and R&D 
cat.no. FAB7267A), CD96 (6A6 and 630612), DNAM-1 
(10E5), IFN-γ (XMG1.2), CD11b (M1/70), CD11c (N418), 
CD19 (1D3), F4/80 (BM8), Ly6C (HK1.4), Ly6G (1A8-
Ly6g), MER TK (DS5MMER), CD169 (3D6.112), SIG NR1 
(cat.no. FAB1836P), CD64 (X54-5/7.1), MHC II (NIMR-4), 
PVR (TX56), B220 (RA3-6B2), PDCA-1 (eBio927), SA-
EF710, and iNOS (CXN FT). For iNOS staining of myeloid 
cell subsets, splenocytes were incubated for 4 h in 10% RPMI 
with Brefeldin A and Monensin (Fig. S1). For IFN-γ staining, 
splenocytes were incubated as described for myeloid subsets, 
with addition of IL-2 (500 IU/ml). Subsequently, cells were 
surface stained, fixed, and permeabilized, followed by intracel-
lular staining. Flow cytometry was performed by FAC SAria, 
FAC SVerse, or FACScan (BD), and data were analyzed using 
FlowJo_v10 (Tree Star) software.
Immunofluorescence
B12 cells were infected with 3 PFU/per cell of recombi-
nant MCMV lacking viral Fc receptor encoded by the m138 
gene. This virus was used to exclude the possibility of the 
rat anti-PVR mAb binding to the viral Fc receptor fcr-1. 
The equivalence of the WT MCMV and Δm138 virus with 
respect to PVR retention phenomenon was confirmed in a 
set of flow cytometry and Western blot analyses. Cells were 
supplemented with lactacystin (10 µM) or leupeptin (75 µg/
µl) from the fourth h.p.i., and then fixed and analyzed for 
PVR after an additional 12 h. PVR was stained with the an-
tibodies described in the Flow cytometry section, mounted 
using Mowiol mounting medium, and analyzed on RT 
with Olympus FV300 confocal laser scanning microscope 
using a PlanApo 60× NA1.4 oil objective (Olympus) and 
FluoView acquisition software.
Western blot analysis
Cell lysates were prepared using NP-40 lysis buffer (10 mM 
Sodium phosphate, pH 7.2, 150 mM sodium chloride, 2 mM 
EDTA, 1% NP-40, and protease inhibitors). Proteins, 75–100 
µg of lysate, were separated on 10–12% SDS-PAGE. For 
EndoH treatment, 75–100 µg of lysate was incubated for 16 h 
with 25 mU of EndoH in 0.1 M phosphate buffer at 37°C. 
Lactacystin and leupeptin were used as described for Immu-
nofluorescence. Membranes were incubated with anti–mouse 
PVR clone 3F1 (Hycult Biotech), anti-actin (EMD Milli-
pore), anti-MCMV m04 (clone m04.10), anti-MCMV M57 
(clone M57.01), and anti-MCMV m20.1 (clone m20.1.01; 
all generated in our laboratory). All samples were visualized 
using the UVITec imaging system.
Coimmunoprecipitation (CoIP)
MEF lysates were prepared as described for Western blot 
analysis and incubated overnight at 4°C under rotation with 
anti-m20.1 mAb, followed by 1-h incubation with protein 
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G–Sepharose beads (50  µl; GE Healthcare). The precipi-
tates were washed five times (1  ml each) with IP buffers 
before the samples were subjected to Western blot analy-
sis. The membranes were incubated with anti–mouse PVR 
clone 3F1 (Hycult Biotech).
Cytokine detection
Mouse Cytokine Array Panel A Array kit (R&D Systems) was 
used according to the manufacturer’s instructions. In brief, 
80–100 µl of sera previously mixed with antibody cocktail 
was added to the precoated membranes and incubated over-
night. The membranes were incubated with streptavidin. The 
results were visualized by ImageQuant imaging system and 
analyzed with the ImageJ software (National Institutes of 
Health) with dot blot analysis plug-in.
Mice
BALB/c, C57BL/6, C57BL/6 SCID, and DNAM-1−/− (on 
C57BL/6 background; Gilfillan et al., 2008) mice were 
housed and bred under specific pathogen–free conditions at 
the Central Animal Facility, Faculty of Medicine, University 
of Rijeka in accordance with the guidelines contained in the 
International Guiding Principles for Biomedical Research 
Involving Animals. The Ethics Committee at the University 
of Rijeka approved all animal experiments. Newborn mice 
and 8–12-wk-old mice were used.
Infection conditions, detection of MCMV, and 
depletion of cell subsets
Adult mice were injected either i.p. or i.v. with tissue cul-
ture–grown recombinant MCMV strains, at indicated doses, 
in a volume of 500 µl of PBS. Organs were harvested at in-
dicated time points, and virus titers were determined by a 
plaque-forming assay. In vivo depletion of NK cells was per-
formed by i.p. injection of the mAbs to NK1.1 (PK136) or 
anti-AGM1 and of mononuclear phagocytes by i.p. injection 
of clodronate liposomes (200  µl, 18  h before infection). In 
vivo blocking of CCL2 was performed by i.p. injection of the 
mAbs to CCL2 (clone 2H5; BioXCell; 200 µg/mouse), 1 d 
before infection and on the day of infection. Newborn BAL-
B/c mice were injected i.p. with 400 PFU of either Δm20.1 
MCMV mutant generated on Δm157 background or Δm157 
MCMV as a control virus in a volume of 50 µl of PBS. Organs 
were harvested 11 d p.i., and virus titers were determined by 
a plaque-forming assay. In vivo inhibition of NOS: l-NAME 
(Sigma-Aldrich) was administered ad libitum in drinking water 
(5 mM) starting 3 d before infection. l-NAME solutions were 
changed daily. Control groups received only drinking water.
Statistical analysis
Statistical significance of the differences between experimen-
tal groups of animals in viral titers was determined by the 
two-tailed Mann–Whitney U test and for surface protein ex-
pression or intracellular iNOS and IFN-γ detection on differ-
ent cell subsets by unpaired, two-tailed Student’s t test.
Online supplemental material
Fig. S1 shows gating strategies for mononuclear phagocytes. 
Online supplemental material is available at http ://www .jem 
.org /cgi /content /full /jem .20151899 /DC1.
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